Asahi Ka­sei fin­ish­es $96M+ phar­ma ex­cip­i­ent man­u­fac­tur­ing plant in Japan

The Japan­ese con­glom­er­ate Asahi Ka­sei has put the fin­ish­ing touch­es on a sec­ond plant to man­u­fac­ture the phar­ma ex­cip­i­ent mi­cro­crys­talline cel­lu­lose (MCC) amid a growth in de­mand.

Asahi Ka­sei to­day an­nounced it has fin­ished build­ing its plant to man­u­fac­ture Ce­o­lus, its brand of MCC. The fa­cil­i­ty is lo­cat­ed at the Mizushi­ma Works in the city of Kurashi­ki, Japan, near Okaya­ma. Ac­cord­ing to Asahi Ka­sei’s re­lease, the fa­cil­i­ty was fin­ished in Jan­u­ary of this year and is part of an ef­fort to grow its MCC out­put due to “sub­stan­tial­ly grow­ing de­mand.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER